CBU
HRMY icon

CIBC Bancorp USA’s Harmony Biosciences HRMY Stock Holding History

CIBC Bancorp USA’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
+6,000
New +$189K ﹤0.01% 1726

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

CIBC Bancorp USA's HRMY Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 6,000 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #1726 among its holdings.

301 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • CIBC Bancorp USA held 6,000 shares of Harmony Biosciences worth $218K as of Q2 2026.
  • Harmony Biosciences was a new CIBC Bancorp USA position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1726 holding.
  • 301 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.